Trade CDXS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Codexis, Inc. (CDXS) is trading at US$1.36, up 3.03% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$182.87M. Over the past 52 weeks, CDXS has traded between US$0.96 and US$2.98. On Syfe you can trade CDXS with $0 commission and add it to your watchlist.
| Previous close | US$1.32 |
|---|---|
| Market cap | US$182.87M |
| 52-week range | US$0.96 – US$2.98 |
| Volume | 2.87M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Codexis, Inc.
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.
Year: 2010
Top Premarket Decliners
Jul 24, 11:43 AM · MT Newswires
Codexis Prices 16.7 Million Shares at $1.50 in Public Stock Offering
Jul 24, 7:54 AM · MT Newswires
Codexis, Inc. (CDXS) stock is trading at US$1.36, +3.03% from the previous close of US$1.32.
The market cap for Codexis, Inc. (CDXS) stock is approximately US$182.87M.
The 52-week high for Codexis, Inc. (CDXS) stock is US$2.98.
The 52-week low for Codexis, Inc. (CDXS) stock is US$0.96.
Codexis, Inc. (CDXS) does not currently pay a dividend.
Stay on top of CDXS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
